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intestinal tract 2〜4）. Recently, REG Ia  protein is report-
edly overexpressed in various malignancies including 
pancreatic 5）, gastric 3, 6, 7） or colorectal cancers 8〜10）, sug-
gesting that REG Ia  protein play a role in the carcino-
genesis of digestive system. The salivary gland is a 
component of the digestive system and its tissue struc-
ture, comprising acinar and ductal cells, is similar to 
that of the exocrine pancreas. Therefore, it is tempting 
to speculate that REG Ia  protein may play some role 
in the development of salivary gland tumors. In the 
present study, we initially determined the immunohis-
tochemical localization of REG Ia  protein in salivary 
gland tumors and moreover investigated its relation-
INTRODUCTION
The regenerating gene （Reg） was originally isolated 
from a complementary DNA （cDNA） library derived 
from regenerating rat pancreatic islets, and its human 
homologue was named REG Ia  1）. REG Ia  protein is 
expressed not only in the pancreas but also the gastro-
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SUMMARY
The regenerating gene （Reg） Ia  protein has a trophic effect on gastric epithelial cells, and its overexpres-
sion is reported in gastrointestinal cancers. The salivary gland is a component of the digestive system, and 
therefore, REG Ia  protein may play some role in the pathophysiology of salivary gland tumors. In the pres-
ent study, we determined the immunohistochemical localization of REG Ia  protein in salivary gland tumors 
and moreover investigated its relationship to clinicopathological features. Twenty-eight patients with sali-
vary gland tumor were enrolled. The specimens resected by surgery from those patients were examined 
using immunohistochemistry for REG Ia  protein and Ki67. Five of the 16 pleomorphic adenomas （31.3％） 
were positive for REG Ia  protein. Regarding salivary gland carcinomas, four of five mucoepidermoid carci-
nomas （80％）, three of five adenoid cystic carcinomas （60％）, one of two polymorphous low-grade adeno-
carcinomas （50％） were also positive for REG Ia  protein. However, no relationships were found between 
REG Ia  protein expression and clinicopathological features. Regarding the Ki67 expression, strong signal 
was observed in the tumor cells of patients with salivary gland adenoma as well as carcinoma. REG Ia  pro-
tein is expressed not only in adenocarcinoma but also precancerous adenoma cells proliferating actively, 
suggesting that REG Ia  protein may play a role at least in part in the development of salivary gland tu-
mors.
　Key Words： REG Ia  protein, proliferation, salivary.
Originals
Tokiko Kimura
Evaluation of REG Ia  expression
We assessed the immunoreactivity of REG Ia  in the 
tissue sections including the invasive front of salivary 
gland tumors. To evaluate the immunoreactivity of 
REG Ia , at least 500 tumor cells were counted in five 
different visual fields for each tumor tissue sample. A 
specimen was considered positive for REG Ia  protein, 
if ≥ 20％ of the tumor cells were positively stained；
otherwise, the specimens were considered negative.
Statistical analysis
Statview 5.0J statistical software （Abacus Concepts 
Inc., Berkeley, CA） was used for all analyses. Chi-
squared analyses were performed to investigate the 
relationship between REG Ia  expression and clinico-
pathological features. All values were expressed as the 
mean±SEM, and the significance of differences be-
tween two groups was assessed using Mann-Whitney 
U-test. Differences at P＜0.05 were considered to be 
significant.
RESULTS
Expression of REG Ia  in salivary gland tumors
The immunoreactivity for REG Ia  protein was hard-
ly observed in the ductal epithelial cells of normal sali-
vary glands. Additionally, no immunoreactivity for 
REG Ia  protein was observed in either acinar or inter-
stitial cells in normal salivary glands （Fig. 1A）.
On the other hand, in salivary gland tumors, REG Ia  
protein immunoreactivity was detected in the cyto-
plasm of tumor cells （Fig. 1B-E）. REG Ia  protein im-
munoreactivity was detected in various types as well 
as stages of salivary gland tumors.
Five of the 16 pleomorphic adenomas （31.3％） were 
positive for REG Ia  protein. Regarding salivary gland 
carcinomas, four of five mucoepidermoid carcinomas 
（80％）, three of five adenoid cystic carcinomas （60％）, 
one of two polymorphous low-grade adenocarcinomas 
（50％） were also positive for REG Ia  protein （Table 
1）. However, no relationships were found between 
REG Ia  protein expression and sex, age, histology or 
stage of carcinoma （Table 1）.
Expression of Ki67 in salivary gland tumors
Immunoreactivity for Ki67 was scattered in the nor-
mal salivary gland （Fig. 2A）. In detail, a few epithelial 
ship to clinicopathological features. 
MATERIALS AND METHODS
Patients, tissue samples, and histology
Twenty-eight patients with salivary gland tumor （10 
males, 18 females；mean age 49.3 y, range 13-85 y） 
who were diagnosed and treated at Dokkyo University 
Hospital between 1994 and 2005 were enrolled. Sam-
ples of salivary gland tissue were obtained by surgery 
from patients with salivary gland tumor, and also from 
5 controls （2 males, 3 females；mean age 40.6 y, range 
34-50 y） who were treated for mucocele. Tissue speci-
mens were fixed in 10％ neutral buffered formalin and 
embedded in paraffin. Multiple hematoxylin-eosin-
stained sections of each sample were examined histo-
logically. The tumor stage was according to the Inter-
national Union Against Cancer TNM staging system11）.
Immunohistochemistry
Immunohistochemical staining was performed with a 
LSAB-2 kit （DAKO, Marseille, France） as described 
previously 3）. Ki67 was used as markers for measures 
of cell proliferation 12）. Anti-human REG Ia  antibody 
was provided by Dr. Okamoto et al. as previously de-
scribed 2）. In brief, 4-mm-thick sections were placed on 
slides, deparaffinized, and dehydrated. They were then 
placed in 0.01 mol/L citrate buffer （pH 6.0） and treat-
ed by microwave heating （MI-77, Azumaya, Tokyo, 
Japan；400 W, 95℃） for 10 and 40 min to facilitate an-
tigen retrieval for REG Ia  and Ki 67, respectively. 
Then, the sections were followed by pretreatment with 
0.3％ H2O2 in methanol for 20 min at room tempera-
ture to quench endogenous peroxidase activity. The 
sections were incubated with 1％ bovine serum albu-
min in phosphate-buffered saline （PBS） for 30 min, 
and then with anti-REG Ia  （dilution 1：100） and anti-
Ki 67 （DAKO Japan, Kyoto, Japan；dilution 1：50） for 
1 hour. Thereafter, the sections were incubated with 
biotinylated secondary antibody for 15 min, washed 
with PBS, and treated with peroxidase-conjugated 
streptavidin for 20 min. Finally, the sections were incu-
bated in 3,3’-diaminobenzidine tetrahydrochloride with 
0.05％ H2O2 for 3 min and then counterstained with 
Mayer’s hematoxylin.
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Figure 1　 Immunostaining of REG Ia  in normal and salivary gland tumor tissues. （A） REG Ia  
expression is negative in any types of cell in normal salivary gland tumor tissues. 
However, REG Ia-immunoreactivity is detectable in the cytoplasm of tumor cells in 
（B） pleomorphic adenoma, （C） polymorphous-low grade adenocarcinoma, （D） 
mucoepidermoid carcinoma, （E） adenoid cystic carcinoma.
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cells per duct showed Ki67 immunoreactivity. Howev-
er, strong immunoreactivity of Ki67 was observed in 
the tumor cells of patients with salivary gland adeno-
ma as well as carcinoma （Fig. 2B-E）. 
DISCUSSION
We have previously shown that REG Ia  protein is 
expressed not only in the pancreas but also in the gas-
trointestinal tract 3, 4）；however, its expression in sali-
vary glands still remained unclear. Since the structure 
of salivary gland is similar to that of the exocrine pan-
creas, we expected that REG Ia  protein would be ex-
pressed in salivary gland as well. However, we ob-
served that REG Ia  protein expression is not 
detectable in normal salivary glands although its ex-
pression is detectable at very high level in the pancre-
as 13）. We have no answer to explain this discrepancy 
but speculate that tissue-specific differences in the 
regulatory mechanism of gene expression may affect 
the level of REG Ia  protein expression. On the other 
hand, it is interesting that REG Ia  protein expression 
is detectable in the dutal epithelial cells in salivary 
glands under inflammatory condition 14）. This finding 
may suggest that the dutal epithelial cells in salivary 
glands have a potential to express REG Ia  protein but 
its expression is suppressed under normal condition.
The most important finding in this study was that a 
considerable number of salivary gland tumors ex-
pressed REG Ia  protein. In detail, REG Ia  expression 
was detectable in the cytoplasm of tumor cells, being 
compatible with the character of REG Ia  as a secreto-
ry protein. Recent studies have reported that not only 
gastroenterological cancers but also lung cancers 15） 
and seminomas 16） express REG Ia  protein, suggesting 
that REG Ia  protein plays a role in the pathogenesis of 
various malignancies. In this context, although we in-
vestigated the relationship between REG Ia  expres-
sion and clinicopathological features in patients with 
salivary gland tumors, we found no relationship be-
tween them. However, since REG Ia  protein has a 
trophic effect on gastrointestinal epithelial cells 17）, we 
furthermore examined whether REG Ia  protein is in-
volved in the cell proliferation in salivary gland tu-
mors. Of note, the distribution of Ki67-positive cells 
was similar to that of REG Ia-positive cells in salivary 
gland tumors, suggesting that REG Ia  protein may be 
associated with the proliferative behavior of tumor 
cells in salivary gland tumors. Moreover, it is notewor-
thy that REG Ia  overexpression was observed not 
only in adenocarcioma but also adenoma cells, suggest-
ing that REG Ia  protein play a role from the early 
stage of carcinogenesis in the salivary glands.
In summary, REG Ia  protein is expressed in various 
salivary gland tumors in histology. Moreover, REG Ia  
protein is expressed not only in adenocarcioma but 
also precancerous adenoma cells proliferating actively. 
These data suggest that REG Ia  protein may play a 
role at least in part in the development of salivary 
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Table 1　Relationship between REG Ia  expression and clinicopathological factors
REG Ia  expression
P value
negative positive
Sex Male/Female 3/6 7/12 NS
Age 54.7±4.0 46.7±5.2 NS
Histology
Pleomorphic adenoma 11 5
NS
Mucoepidermoid carcinoma 1 4
Adenoid cystic carcinoma 2 3
Polymorphous low-grade Ad Ca 1 1
Adenoma 5 10
NS
Carcinoma 4 9
Stage 　  I 2 8
NS
II, III, IV 7 11
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Figure 2　 Immunostaining of Ki67 in normal and salivary gland tumor tissues. （A） Ki67 
immunoreactivity is scattered in the normal salivary gland tissues. However, 
strong signal of Ki67 immunoreactivity is detectable in the nuclei of tumor cells in 
（B） pleomorphic adenoma, （C） polymorphous-low grade adenocarcinoma, （D） 
mucoepidermoid carcinoma, （E） adenoid cystic carcinoma.
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gland tumors. REG Ia  expression has been recently 
suggested to be useful to predict the prognosis in pa-
tients with gastrointestinal cancers 6〜8）. In this regard, 
we will need to investigate the prognostic significance 
of REG Ia  expression in patients with salivary gland 
tumors.
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